Overview

• L’Oreal has acquired a majority stake in Medik8 from private equity firm Inflexion, which retains a minority share, under undisclosed financial terms.
• Medik8 is known for its vitamin A–based anti-ageing creams and serums and reported £15.6 million pre-tax profit on £45.3 million revenue for the year to September 2023.
• L’Oreal’s dermocosmetics arm, including CeraVe, La Roche-Posay and SkinCeuticals, generated €7 billion in revenue in 2024.
• Founder Elliot Isaacs will remain on Medik8’s board and CEO Simon Coble will continue leading the brand under L’Oreal’s ownership.
• L’Oreal plans to leverage its global distribution network to expand Medik8 into new markets and has pursued similar dermocosmetics deals with Dr.G, Amourage and Galderma.